Home
Acorn Bioventures reported a 5.2% stake in Candel Therapeutics CADL · 2,580,517 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.2%
- Last report
- First report
- Shares held
- 2,580,517 sh
- Class
- Common stock, par value $0.0001 per share
- Holder
- Acorn Bioventures
- Event date
- 25/06/25
- Filed
- 25/06/30
First 5%+ report · 5.2% stake
Candel Therapeutics trades, last 26 weeks
What else happened in Candel Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/26~25/07/25Acorn Bioventures's other 5% stake reports
- Acorn Bioventures
5% stakeKaryopharm Therapeutics
5% stakeKaryopharm Therapeutics
KPTI
5.7% stake
1,284,221 sh
5.7% stake
Filed 09/25
- Acorn Bioventures
5% stakeLeonaBio
5% stakeLeonaBio
LONA
12.1% stake
1,492,521 sh
12.1% stake
Filed 08/20
- Acorn Bioventures
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
5% stake
3,357,282 sh
5% stake
Filed 07/22
- Acorn Bioventures
5% stakeKaryopharm Therapeutics
5% stakeKaryopharm Therapeutics
KPTI
6.7% stake
1,518,113 sh
6.7% stake
Filed 05/15
- Acorn Bioventures
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
9.5% stake
3,924,037 sh
9.5% stake
Filed 04/01